Tempsens Instruments Allotment Today: GMP Indicates 105% Listing Gains—Check Your Status Now!

The Tempsens Instruments IPO, which opened for subscription from August 20 to August 24, is set to complete its allotment process today, August 25, 2026. The public issue of Rs 650 crore has garnered an exceptional subscriber interest, being oversubscribed by 184.07 times overall, with the retail tranche subscribed 60.69 times and the QIB and NII segments receiving subscriptions of 302.88 times and 314.44 times, respectively. The company aims to list its shares on both the NSE and BSE on August 28.

Currently, the grey market premium (GMP) stands at a robust 105%, indicating a potential listing price of around Rs 613 per share based on the upper band of the IPO price of Rs 300. This sentiment suggests that investors are optimistic about significant listing gains, but as always, it is important to note that GMP can fluctuate leading up to the actual trading debut. The premium reflects a strong demand for the stock, bolstered by a solid financial performance and a well-received growth strategy by the company.

For Indian investors, the enthusiasm surrounding the Tempsens Instruments IPO represents a promising opportunity for portfolio diversification and potential short-term gains. The substantial oversubscription, coupled with positive GMP, underscores investor confidence in the company’s growth prospects in the thermal engineering sector. With the fresh capital aimed at bolstering its operational capabilities and strengthening its financial health, the listing could mark a significant milestone for retail investors looking to capitalize on the stock’s initial performance.

💡
• WEALTHOVA INSIGHTS

The strong demand for Tempsens Instruments IPO signals robust interest in the thermal engineering segment. Investors should monitor the listing closely to assess their entry points and long-term investment potential.

Disclaimer: Market insights and analyses on Wealthova are strictly for educational and informational purposes and do not constitute financial or investment advice. Please consult a SEBI-registered financial advisor before making investment decisions.


Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova IPO team.)